GrippeCanadaV3, Main, Exploration, bibRecord, 000755

Statement on influenza vaccination for the 2008-2009 season. An Advisory Committee Statement (ACS).

Identifieur interne : 000755 ( Main/Exploration ); précédent : 000754; suivant : 000756

Statement on influenza vaccination for the 2008-2009 season. An Advisory Committee Statement (ACS).

Auteurs :

Source :

Canada communicable disease report = Releve des maladies transmissibles au Canada [ 1481-8531 ] ; 2008.

RBID : pubmed:18802991

Descripteurs français

KwdFr :
- Adulte, Antiviraux (administration et posologie), Antiviraux (usage thérapeutique), Canada (épidémiologie), Femelle, Grippe humaine (), Grippe humaine (virologie), Grippe humaine (épidémiologie), Grossesse, Humains, Nourrisson, Oséltamivir (administration et posologie), Oséltamivir (usage thérapeutique), Sous-type H1N1 du virus de la grippe A, Sous-type H3N2 du virus de la grippe A, Sujet âgé, Sujet âgé de 80 ans ou plus, Vaccins antigrippaux (administration et posologie), Virus influenza B, Zanamivir (administration et posologie), Zanamivir (usage thérapeutique).
MESH :
- administration et posologie : Antiviraux, Oséltamivir, Vaccins antigrippaux, Zanamivir.
- usage thérapeutique : Antiviraux, Oséltamivir, Zanamivir.
- virologie : Grippe humaine.
- épidémiologie : Canada, Grippe humaine.
- Adulte, Femelle, Grippe humaine, Grossesse, Humains, Nourrisson, Sous-type H1N1 du virus de la grippe A, Sous-type H3N2 du virus de la grippe A, Sujet âgé, Sujet âgé de 80 ans ou plus, Virus influenza B.
Wicri :
- geographic : Canada.

English descriptors

KwdEn :
- Adult, Aged, Aged, 80 and over, Antiviral Agents (administration & dosage), Antiviral Agents (therapeutic use), Canada (epidemiology), Female, Humans, Infant, Influenza A Virus, H1N1 Subtype, Influenza A Virus, H3N2 Subtype, Influenza B virus, Influenza Vaccines (administration & dosage), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Influenza, Human (virology), Oseltamivir (administration & dosage), Oseltamivir (therapeutic use), Pregnancy, Zanamivir (administration & dosage), Zanamivir (therapeutic use).
MESH :
- chemical , administration & dosage : Antiviral Agents, Influenza Vaccines, Oseltamivir, Zanamivir.
- chemical , therapeutic use : Antiviral Agents, Oseltamivir, Zanamivir.
- geographic , epidemiology : Canada.
- epidemiology : Influenza, Human.
- prevention & control : Influenza, Human.
- virology : Influenza, Human.
- Adult, Aged, Aged, 80 and over, Female, Humans, Infant, Influenza A Virus, H1N1 Subtype, Influenza A Virus, H3N2 Subtype, Influenza B virus, Pregnancy.

PubMed: 18802991

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000803
to stream Main, to step Curation: 000803

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Statement on influenza vaccination for the 2008-2009 season. An Advisory Committee Statement (ACS).</title>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2008">2008</date>
<idno type="RBID">pubmed:18802991</idno>
<idno type="pmid">18802991</idno>
<idno type="wicri:Area/Main/Corpus">000803</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000803</idno>
<idno type="wicri:Area/Main/Curation">000803</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000803</idno>
<idno type="wicri:Area/Main/Exploration">000803</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Statement on influenza vaccination for the 2008-2009 season. An Advisory Committee Statement (ACS).</title>
</analytic>
<series><title level="j">Canada communicable disease report = Releve des maladies transmissibles au Canada</title>
<idno type="eISSN">1481-8531</idno>
<imprint><date when="2008" type="published">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Antiviral Agents (administration & dosage)</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Canada (epidemiology)</term>
<term>Female</term>
<term>Humans</term>
<term>Infant</term>
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza A Virus, H3N2 Subtype</term>
<term>Influenza B virus</term>
<term>Influenza Vaccines (administration & dosage)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Influenza, Human (virology)</term>
<term>Oseltamivir (administration & dosage)</term>
<term>Oseltamivir (therapeutic use)</term>
<term>Pregnancy</term>
<term>Zanamivir (administration & dosage)</term>
<term>Zanamivir (therapeutic use)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Antiviraux (administration et posologie)</term>
<term>Antiviraux (usage thérapeutique)</term>
<term>Canada (épidémiologie)</term>
<term>Femelle</term>
<term>Grippe humaine ()</term>
<term>Grippe humaine (virologie)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Grossesse</term>
<term>Humains</term>
<term>Nourrisson</term>
<term>Oséltamivir (administration et posologie)</term>
<term>Oséltamivir (usage thérapeutique)</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Sous-type H3N2 du virus de la grippe A</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Vaccins antigrippaux (administration et posologie)</term>
<term>Virus influenza B</term>
<term>Zanamivir (administration et posologie)</term>
<term>Zanamivir (usage thérapeutique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiviral Agents</term>
<term>Influenza Vaccines</term>
<term>Oseltamivir</term>
<term>Zanamivir</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term>
<term>Oseltamivir</term>
<term>Zanamivir</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Canada</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Antiviraux</term>
<term>Oséltamivir</term>
<term>Vaccins antigrippaux</term>
<term>Zanamivir</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term>
<term>Oséltamivir</term>
<term>Zanamivir</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Canada</term>
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Female</term>
<term>Humans</term>
<term>Infant</term>
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza A Virus, H3N2 Subtype</term>
<term>Influenza B virus</term>
<term>Pregnancy</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Femelle</term>
<term>Grippe humaine</term>
<term>Grossesse</term>
<term>Humains</term>
<term>Nourrisson</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Sous-type H3N2 du virus de la grippe A</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Virus influenza B</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Canada</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18802991</PMID>
<DateCompleted><Year>2008</Year>
<Month>09</Month>
<Day>19</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1481-8531</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>34</Volume>
<Issue>ACS-3</Issue>
<PubDate><Year>2008</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Canada communicable disease report = Releve des maladies transmissibles au Canada</Title>
<ISOAbbreviation>Can. Commun. Dis. Rep.</ISOAbbreviation>
</Journal>
<ArticleTitle>Statement on influenza vaccination for the 2008-2009 season. An Advisory Committee Statement (ACS).</ArticleTitle>
<Pagination><MedlinePgn>1-46</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><CollectiveName>National Advisory Committee on Immunization (NACI)</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<Language>fre</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>Canada</Country>
<MedlineTA>Can Commun Dis Rep</MedlineTA>
<NlmUniqueID>9303729</NlmUniqueID>
<ISSNLinking>1188-4169</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>20O93L6F9H</RegistryNumber>
<NameOfSubstance UI="D053139">Oseltamivir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>L6O3XI777I</RegistryNumber>
<NameOfSubstance UI="D053243">Zanamivir</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053122" MajorTopicYN="N">Influenza A Virus, H3N2 Subtype</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009981" MajorTopicYN="N">Influenza B virus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007252" MajorTopicYN="Y">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053139" MajorTopicYN="N">Oseltamivir</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053243" MajorTopicYN="N">Zanamivir</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year>
<Month>9</Month>
<Day>20</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2008</Year>
<Month>9</Month>
<Day>20</Day>
<Hour>9</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2008</Year>
<Month>9</Month>
<Day>20</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">18802991</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list></list>
<tree></tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000755 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000755 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    GrippeCanadaV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:18802991
   |texte=   Statement on influenza vaccination for the 2008-2009 season. An Advisory Committee Statement (ACS).
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:18802991" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeCanadaV3

This area was generated with Dilib version V0.6.35.
Data generation: Tue Jul 7 13:36:58 2020. Site generation: Sat Sep 26 07:06:42 2020

	Corpus GrippeCanadaV3
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Corpus GrippeCanadaV3

Statement on influenza vaccination for the 2008-2009 season. An Advisory Committee Statement (ACS).

Statement on influenza vaccination for the 2008-2009 season. An Advisory Committee Statement (ACS).

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki